The global clinical trial management systems market size was valued around US$ 1.4 billion in the year 2019. The market is anticipated to rise at an astonishing 13.3% CAGR. Rising at this CAGR, the market is projected to touch a valuation of US$ 3.5 billion by the end of 2027.
The growing clinical trials failure rates, lengthy clinical trials approval time, and strict government guidelines are likely to hamper the growth of the clinical trial management system market. Drug research has gained momentum in the past few years. It has led to the need for a standard platform for the management of data and results.
Rising prevalence of chronic diseases such as cancer, diabetes, etc. has led to a drastic rise in the demand for effective drugs and treatments. This, in turn, has intensified the need for clinical trials, which is likely to boost the revenue generation of the clinical trial management system market in the years to come. In addition, the developments in the healthcare IT industry is poised to act as a growth catalyst for market players. However, the implementation of stricter regulations, coupled with the rising rate of clinical trials failure is anticipated to undermine market growth in the years to come.
Overview
Assimilation of Clinical Trial Management Systems (CTMS) with Hospital Information System (HIS) To Drive Market
Cloud-based Clinical Trial Management System Represents the Remarkable Growth
Software is anticipated to be Most Lucrative Segment
Enterprise-Based Clinical Trial Management System Is Set to Poise the Highest Growth
Pharmaceutical Industries to Dominate the Global Market
North America to Dominate Global Market
Competitive Analysis
eClinForce, Inc., Forte Research Systems Inc., Oracle, iWeb Technologies, Medidata Solutions, PAREXEL, Bio-Optronics, Bioclinica, and IBM are some of the key vendors contributing to the development of the global clinical trial management system market. These players are poised to devise growth strategies that are expected to lead the growth trajectory of the global market over the next couple of years. Some of the growth strategies opted by the market participants are mergers & acquisitions, partnerships, collaborations, product portfolio development, and technological innovation, among others.
Market Segmentation
The global clinical trial management system market research has been segmented on the basis of type, delivery model, component, and end-user.
On the basis of type, the market has been classified as an enterprise clinical trial management system and site clinical trial management system.
On the basis of delivery model, the market has been classified as web-based (Hosted CTMS), licensed enterprise and cloud-based CTMS.
On the basis of component, the market has been classified as software and service.
On the basis of end-user, the market has been classified as medical device manufacturers, pharmaceutical and biopharmaceutical companies, contract research organizations, and others.
On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
Regional Analysis
On the basis of region, the study of the global Clinical Trial Management System Market spans across four regions – Asia Pacific, the Middle East & Africa (MEA), Europe, and Americas.
Americas is set to dictate the growth pattern of the global market over the next couple of years owing to the presence of robust healthcare IT industry. Europe, at the second spot, is poised to witness increasing investments. This, in turn, is projected to benefit the growth rate of the clinical trial management system market in the region. Asia Pacific is also prognosticated to grow substantially due to the rapid developments being observed in the healthcare sector.
Latest Developments in the Global Clinical Trial Management System Market:
In July 2019, ObjectiveGI, a gastrointestinal-focused clinical research company, has collaborated with Clinical Research IO has announced the launch of a clinical research electronic source model for direct data capture research capabilities. The ObjectiveGI platform introduced offers clinical research data management to physicians and the patients participating in the concerned research with enhanced quality and efficiency.
In July 2019, Symbio, the New York-based Contract Research Organization (CRO), has collaborated with OmniComm, a data management technology company. The companies have signed a five year agreement for managing and developing clinical study databases.
In July 2019, Veeva Systems, a cloud-computing company focused on pharmaceutical and life sciences, has been selected by a global medical device company, Alcon, for the deployment of Veeva Vault Clinical Data Management System (CDMS) for electronic data capture (EDC).
CHAPTER 1. Preface
1.1.Report Scope and Market Segmentation
1.2.Research Highlights
1.3.Assumptions and Acronyms Used
CHAPTER 2. Research Methodology
CHAPTER 3. Executive Summary : Global Clinical Trial Management System Market
CHAPTER 4. Market Overview
4.1. Introduction
4.1.1. Clinical Trial Management System Definition
4.1.2. Key Industry Evolutions/ Developments
4.2. Overview: Global Clinical Trial Management System (CTSM) Market
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunities
4.5. Porter’s Five Force Analysis
4.6. Product Pipeline
4.7. Standards for data management in clinical trial study
5. Global Clinical Trial Management System (CTMS) Market Analysis, by Mode of Delivery
5.1. Introduction & Definition
5.2. Key Findings
5.3. Market Value Forecast, by Mode of Delivery , 2015–2025
5.3.1. On-premise
5.3.2. Web-based
5.3.3. Cloud-based
5.4. Market Attractiveness, by Mode of Delivery
6. Global Clinical Trial Management System (CTMS) Market Analysis, by Component
6.1. Introduction & Definition
6.2. Key Findings
6.3. Market Value Forecast, by Component, 2015–2025
6.3.1. Software
6.3.2. Hardware
6.3.3. Services
6.4. Market Attractiveness, by Components
7. Global Clinical Trial Management System (CTMS) Market Analysis, by Type
7.1. Introduction & Definition
7.2. Key Findings
7.3. Market Value Forecast, by Type, 2015–2025
7.3.1. Enterprise-based
7.3.2. Site-based
7.4. Market Attractiveness, by Type
8. Global Clinical Trial Management System (CTMS) Market Analysis, by End-user
8.1. Introduction & Definition
8.2. Key Findings
8.3. Market Value Forecast, by End-user, 2015–2025
8.3.1. Pharmaceutical Industries
8.3.2. Contract Research Organizations
8.3.3. Healthcare Providers
8.4. Market Attractiveness, by End-user
9. Global Clinical Trial Management System (CTMS) Market Analysis, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia
9.2.4. Rest of the World
9.3. Market Attractiveness by Region
10. North America Clinical Trial Management System Analysis and Forecast
10.1. Key Findings
10.2. North America Clinical Trial Management System (CTMS) Market Overview
10.3. Market Value Share, by Country/Sub-regions
10.3.1. U.S.
10.3.2. Canada
10.4. Market Value Share, by Mode of Delivery
10.4.1. Cloud-bases
10.4.2. Web-based
10.4.3. On-premise
10.5. Market Value Share, by Component
10.5.1. Software
10.5.2. Hardware
10.5.3. Services
10.6. Market Value Share, by Type
10.6.1. Enterprise-based
10.6.2. Site-based
10.7. Market Value Share, by End-user
10.7.1. Pharmaceutical Industries
10.7.2. Contract Research Organizations
10.7.3. Healthcare Providers
10.8. Market Attractiveness Analysis
10.8.1. By Country/Sub-region
10.8.2. By Mode of Delivery
10.8.3. By Component
10.8.4. By Type
10.8.5. By End-user
11. Europe Clinical Trial Management System Analysis and Forecast
11.1. Key Findings
11.2. Europe Clinical Trial Management System (CTMS) Market Overview
11.3. Market Value Share, by Country/Sub-regions
11.3.1. U.K.
11.3.2. France
11.3.3. Germany
11.3.4. Russia
11.3.5. Poland
11.3.6. Rest of Europe
11.4. Market Value Share, by Mode of Delivery
11.4.1. Cloud-based
11.4.2. Web-based
11.4.3. On-premise
11.5. Market Value Share, by Component
11.5.1. Software
11.5.2. Hardware
11.5.3. Services
11.6. Market Value Share, by Type
11.6.1. Enterprise-based
11.6.2. Site-based
11.7. Market Value Share, by End-user
11.7.1. Pharmaceutical Industries
11.7.2. Contract Research Organizations
11.7.3. Healthcare Providers
11.8. Market Attractiveness Analysis
11.8.1. By Country/Sub-region
11.8.2. By Mode of Delivery
11.8.3. By Component
11.8.4. By Type
11.8.5. By End-user
12. Asia Clinical Trial Management System Analysis and Forecast
12.1. Key Findings
12.2. Asia Clinical Trial Management System (CTMS) Market Overview
12.3. Market Value Share, by Country/Sub-regions
12.3.1. China
12.3.2. South Korea
12.3.3. Taiwan
12.3.4. India
12.3.5. Rest of Asia
12.4. Market Value Share, by Mode of Delivery
12.4.1. Cloud-based
12.4.2. Web-based
12.4.3. On-premise
12.5. Market Value Share, by Component
12.5.1. Software
12.5.2. Hardware
12.5.3. Services
12.6. Market Value Share By Type
12.6.1. Enterprise-based
12.6.2. Site-based
12.7. Market Value Share By End-user
12.7.1. Pharmaceutical Industries
12.7.2. Contract Research Organizations
12.7.3. Healthcare Providers
12.8. Market Attractiveness Analysis
12.8.1. By Country/Sub-region
12.8.2. By Mode of Delivery
12.8.3. By Component
12.8.4. By Type
12.8.5. By End-user
13. Rest of World (ROW) Clinical Trial Management System Market Analysis and Forecast
13.1. Key Findings
13.2. ROW Clinical Trial Management System (CTMS) Market Overview
13.3. Market Value Share By Mode of Delivery
13.3.1. Cloud-based
13.3.2. Web-based
13.3.3. On-premise
13.4. Market Value Share By Component
13.4.1. Software
13.4.2. Hardware
13.4.3. Services
13.5. Market Value Share By Type
13.5.1. Enterprise-based
13.5.2. Site-based
13.6. Market Value Share By End-user
13.6.1. Pharmaceutical Industries
13.6.2. Contract Research Organizations
13.6.3. Healthcare Providers
13.7. Market Attractiveness Analysis
13.7.1. By Mode of Delivery
13.7.2. By Component
13.7.3. By Type
13.7.4. By End-user
14. Competition Landscape
14.1.Market Player – Competition Matrix (By Tier and Size of companies)
14.2.Market Share Analysis By Company (2016)
14.3.Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
14.3.1. Oracle
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Financial Overview
14.3.1.3. Product Portfolio
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Medidata
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Financial Overview
14.3.2.3. Product Portfolio
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. PAREXEL International Corporation
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Financial Overview
14.3.3.3. Product Portfolio
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. International Business Machines Corporation
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Financial Overview
14.3.4.3. Product Portfolio
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. Cinven
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Financial Overview
14.3.5.3. Product Portfolio
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. MedNet Solutions, Inc
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Financial Overview
14.3.6.3. Product Portfolio
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. Microsoft
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Financial Overview
14.3.7.3. Product Portfolio
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. Apple Inc
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Financial Overview
14.3.8.3. Product Portfolio
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. Bio-Optronics, Inc.
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Financial Overview
14.3.9.3. Product Portfolio
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
14.3.10. Cognizant Technology Solutions Corporation
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Financial Overview
14.3.10.3. Product Portfolio
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview
14.3.11. DSG, Inc.
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Financial Overview
14.3.11.3. Product Portfolio
14.3.11.4. SWOT Analysis
14.3.11.5. Strategic Overview
14.3.12. Forte Research Systems, Inc.
14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.12.2. Financial Overview
14.3.12.3. Product Portfolio
14.3.12.4. SWOT Analysis
14.3.12.5. Strategic Overview
14.3.13. Veeva Systems
14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.13.2. Financial Overview
14.3.13.3. Product Portfolio
14.3.13.4. SWOT Analysis
14.3.13.5. Strategic Overview
14.3.14. DATATRAK Int
14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.14.2. Financial Overview
14.3.14.3. Product Portfolio
14.3.14.4. SWOT Analysis
14.3.14.5. Strategic Overview